In October 2016, Nicklaus Children’s Hospital, a flagship of Miami Children’s Health System announced that it acquired a new intraoperative magnetic resonance imaging (iMRI) system. This move will make it the first pediatric facility in Florida that has purchased the new equipment. This will also allow the MRI technology to distinguish between health and unhealthy brain tissue to improve safety and ensure that the tumors are eliminated. It will also help in safeguarding the healthy tissue. The new system is fixed to a ceiling-mounted track system that will bring the MRI to the child in the surgical suite. The new iMRI system allows surgeons to study high-resolution magnetic resonance images that offer surgeon’s useful insights related to the infected area and if the targeted area is treated well. Further, the new system helps decide whether added surgical plans need to be modified to regulate smooth completion of the procedure. The new system is kept in a separate suite when it is not in use where it can potentially be used for MRI procedures for the other hospital patients that require anesthesia monitoring. It is integrated with the facilities neuro-navigation application in the operating suite. It offers guidance to surgeons with guidance similar to the GPS for the brain. Dr. John Ragheb, Director of the Division of Neurosurgery said, “Studies demonstrate that use of an intraoperative MRI improves safety and the effectiveness of surgery, therefore giving the best possible neurosurgical results in the hands of an experienced surgical team.” The Division of Pediatric Neurosurgery at Nicklaus Children’s is a part of the famous Brain Institute at the hospital. The neurosurgeons at the Brain Institute are medical experts that treat children with brain tumors, epilepsy, and other notable brain injuries.
Enquire about report here @ http://bit.ly/2lu9wNV
In January 2017, the American Hospital Dubai announced that the onset of a new diagnostic procedure for the treatment of prostate cancer—one of the most commonly diagnosed cancer and also a major cause of death among men. The new technology marks a significant advancement in prostate cancer screening and treatment in the last 30 years according to the hospital. Prostate cancer cannot be detected easily and the conventional tests could be misleading. According to experts, even though the medical field has shown significant advancements, there is lack of evidence and this can the process of evaluation and assessment difficult. The Fusion Guided Biopsy technique makes use of the advanced hardware and software to detect prostate cancer at an early stage. It more or less merges the existing diagnostic techniques i.e. MRI (magnetic resonance imaging) and ultrasound. Dr. Reinhold Zimmermann, consultant urologist, American Hospital Dubai said that the traditional methods and techniques have not shown progress in the last three decades and digital evaluation is not an effective screening tool anymore. The new technology is a vital advancement in the diagnosis of prostate cancer. The advantages associated to the new technology are enormous and the adoption rate for the same is on the rise.
The global intraoperative MRI market has a lot of scope and potential to grow in the coming years. The reluctant efforts and study by researchers and doctors is projected to create several growth prospects for the market. A report added by Big Market Research recently highlights the important parameters of the global intraoperative MRI market, such as the market share, size, and growth.
Request for discount here @ http://bit.ly/2kPXxLM
About Company :
Big Market Research uniqueness lies in its highly ethical reports at economical rates because we value your relationship and growth more than money. Your growth is our aim. With the arsenal of different search reports, we help you here to look and buy research reports that will be helpful to you and your organization. Our research reports have the capability and authenticity to support your organization for growth and consistency.
Contact Us :